Price to Explore Your Own DNA Has Dropped from $999 to $299 in Just Five Years Mountain View, CA – May 11, 2012 –
23andMe, a leading personal genetics company, today restructured pricing in order to help more individuals explore their own DNA and participate directly in research. Effective today, 23andMe will offer its Personal Genome Service® for just $299 – a $100 reduction in price and a drop of $700 since the service first launched in 2007. 23andMe’s Personal Genome Service® enables individuals to explore their own DNA and provides more than 200 health and traits reports as well as genetic ancestry information. When the service first launched five years ago, it cost $999 and provided just 14 reports. The company is now offering its Personal Genome Service® for a simple single payment, ending its subscription pricing options effective today. Subscription customers who’ve fulfilled their initial contract commitment will simply no longer need to pay a monthly fee while continuing to enjoy their Personal Genome Service®. “We’ve explored many pricing structures to make our service as accessible as possible,” said Anne Wojcicki, 23andMe CEO. “We concluded, a single price model without subscriptions is the best option for both 23andMe and for our customers.” In addition to adjusting its pricing structure, the company has also focused on improving operational efficiencies. As a result, the company is now able to provide customers with their initial genetic analysis within just two to three weeks, reducing laboratory-processing time by more than a month. “Once an individual decides to be a customer, we want to get them their data as quickly as possible. Getting customers their data fast is a high priority,” noted Wojcicki. An ongoing service, 23andMe’s Personal Genome Service® provides a wealth of information about an individual’s DNA and updates about new research. Customers can also choose to participate in the company’s unique research programs. By completing online surveys, customers contribute directly to genetic research that can potentially lead to better understanding of and new treatments for a variety of health conditions. To learn more, visit www.23andMe.com
23andMe, Inc. is the leading consumer genetics and research company. Founded in 2006, the mission of the company is to help people access, understand and benefit from the human genome. The company was named by MIT Technology Review to its “50 Smartest Companies, 2017” list, and named one of Fast Company’s “25 Brands That Matter Now, 2017.” 23andMe has millions of customers worldwide, with ~ 85 percent of customers consented to participate in research. 23andMe, Inc. is located in Mountain View, CA. More information is available at www.23andMe.com.